Semnur Pharmaceuticals, Inc.

SMNR · OTC · SIC 2834: Pharmaceutical Preparations
68
SEC Filings

Business Summary

3 Item 1A. Risk Factors 37 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 104 Item 2. Properties 105 Item 3. Legal Proceedings 105 Item 4. Mine Safety Disclosures 105 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 106 Item 6. [Reserved] 106 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 107 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 11...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSMNRdiscussed_in_filing Cybersecurity
topic_mentionSMNRdiscussed_in_filing Cybersecurity
topic_mentionSMNRdiscussed_in_filing Cybersecurity
topic_mentionSMNRdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001193125-26-082642EDGAR110K words
2025-04-022024-12-310001213900-25-027319EDGAR—
2024-04-012023-12-310001213900-24-028809EDGAR—
2023-03-172022-12-310001575872-23-000375EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277536EDGAR78K words
2025-08-152025-06-300001213900-25-077047EDGAR—
2025-05-162025-03-310001213900-25-044889EDGAR—
2024-11-192024-09-300001213900-24-100217EDGAR—
2024-08-192024-06-300001213900-24-070799EDGAR—
2024-05-222024-03-310001213900-24-045702EDGAR—
2023-11-092023-09-300001213900-23-085292EDGAR—
2023-08-152023-06-300001213900-23-067759EDGAR—
2023-05-152023-03-310001575872-23-000755EDGAR—
2022-11-162022-09-300001575872-22-001134EDGAR—
2022-08-122022-06-300001575872-22-000781EDGAR—
2022-05-232022-03-310001575872-22-000450EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001193125-26-110816EDGAR4K words
2025-12-030001193125-25-306757EDGAR—
2025-09-260001193125-25-220455EDGAR—
2025-09-040001213900-25-084180EDGAR—
2025-08-220001213900-25-079504EDGAR—
2025-08-110001213900-25-073907EDGAR—
2025-07-280001213900-25-068263EDGAR—
2025-07-110001213900-25-063294EDGAR—
2025-06-120001213900-25-053576EDGAR—
2025-05-120001213900-25-041653EDGAR—

68 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001913577
TickerSMNR
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e5d8007393c1e2dfe5667c4380fbad362834949487ea515438853c5396f454f5
parent: f60ed3ec443455b990442192de0d4002bafd3f1c4bd8487895bcc9abede058ee
content hash: 831343db915b746c9fbb65f74e099c55810124833582f32a40305005c4625d49
signed: 2026-04-13T04:47:30.119Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf